logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

The Christie And Salford Royal Nhs Foundation Trusts

Scholars4
Papers4
Citations0
Related Papers (4)
Publication Date
delete
Future Directions of the National Prostate Cancer Audit
errClinical Oncology
IF3
err2026-01-31
err0
PREAI
errJustin K.H. Liu; Arjun Nathan; Joanna Dodkins; Marina A. Parry; Emily Mayne; Adrian Cook; Kit Ying Yuen; Aurelia Chen; Matthew G. Parry; Thomas E. Cowling; Alison C. Tree; Noel W. Clarke; Jan van der Meulen
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
errEuropean Urology
IF25.2
err2025-06-26
err0
errOAAI
errSarah Burdett; David J. Fisher; Jayne F. Tierney; Adrian D. Cook; Daniel E. Spratt; James J. Dignam; Wendy F. Seiferheld; Amar U. Kishan; Yilun Sun; Sylvie Chabaud; Jason A. Efstathiou; Christopher C. Parker; Alan Pollack; Paul Sargos; Igor Latorzeff; Meryem Brihoum; Charles N. Catton; Noel W. Clarke; Felix Y. Feng; Theodore G. Karrison; Pascal Pommier; Howard M. Sandler; Matthew R. Sydes; Claire L. Vale
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
errEuropean Urology Oncology
IF9.3
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave